NasdaqCM - Delayed Quote USD

Achieve Life Sciences, Inc. (ACHV)

3.7600
-0.0700
(-1.83%)
At close: June 9 at 4:00:01 PM EDT
3.8100
+0.05
+(1.33%)
After hours: June 9 at 6:11:42 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
45,981
39,069
27,250
40,800
33,094
Operating Income
-45,981
-39,069
-27,250
-40,800
-33,094
Net Non Operating Interest Income Expense
758
176
-2,028
-1,590
17
Other Income Expense
-937
-934
-537
40
-75
Pretax Income
-46,160
-39,827
-29,815
-42,350
-33,152
Net Income Common Stockholders
-46,160
-39,827
-29,815
-42,350
-33,152
Diluted NI Available to Com Stockholders
-46,160
-39,827
-29,815
-42,350
-33,152
Basic EPS
-1.35
-1.24
-1.50
-4.00
-4.08
Diluted EPS
-1.35
-1.24
-1.50
-4.00
-4.08
Basic Average Shares
34,480.3800
32,071.1460
19,827.3540
10,593.0340
8,119.8360
Diluted Average Shares
34,480.3800
32,071.1460
19,827.3540
10,593.0340
8,119.8360
Total Expenses
45,981
39,069
27,250
40,800
33,094
Net Income from Continuing & Discontinued Operation
-46,160
-39,827
-29,815
-42,350
-33,152
Normalized Income
-45,217
-38,923
-29,287
-42,350
-33,152
Interest Income
2,310
2,356
825
199
17
Interest Expense
1,552
2,180
2,853
1,789
0
Net Interest Income
758
176
-2,028
-1,590
17
EBIT
-44,608
-37,647
-26,962
-40,561
-33,152
EBITDA
-44,374
-37,418
-26,734
-40,325
-32,902
Reconciled Depreciation
234
229
228
236
250
Net Income from Continuing Operation Net Minority Interest
-46,160
-39,827
-29,815
-42,350
-33,152
Total Unusual Items Excluding Goodwill
-943
-904
-528
0
0
Total Unusual Items
-943
-904
-528
0
0
Normalized EBITDA
-43,431
-36,514
-26,206
-40,325
-32,902
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 10/12/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XBIO Xenetic Biosciences, Inc.
3.1450
+6.38%
 
AKTX Akari Therapeutics, Plc
1.2500
+1.46%
 
TCRX TScan Therapeutics, Inc.
1.7700
-1.67%
 
INMB INmune Bio, Inc.
7.65
+0.39%
 
MLYS Mineralys Therapeutics, Inc.
16.19
+0.43%
 
ALDX Aldeyra Therapeutics, Inc.
2.6700
+0.38%
 
VTVT vTv Therapeutics Inc.
16.61
+1.82%
 
IFRX InflaRx N.V.
0.8500
+2.40%
 
SPRY ARS Pharmaceuticals, Inc.
14.53
+0.28%
 
CAPR Capricor Therapeutics, Inc.
13.38
-5.97%